On December 23, 2020, NHS England and NHS Improvement published the final document for updating the National Genomic Test Directory (Test Directory), as well as other documents supporting the application process.
Test Directory was established in 2018 within a new NHS Genomic Medicine Service (GMS) framework. Test Directory identifies the full range of genomic tests – from whole-genome sequencing (WGS) to tests for single genes and molecular markers – that are commissioned by the NHS in England. The Test Directory sets out the technology by which tests are available and the patients who will be eligible to access a test. The NHS Genomic Laboratory Hubs (GLHs) are responsible for delivering the testing outlined in the Test Directory.
The following documents and forms were issued:
- Updating the National Genomic Test Directory
- Updating the National Genomic Test Directory: Consultation response
- National Genomic Test Directory: Frequently Asked Question
- Test Evaluation Application - New Clinical Indication
- Test Evaluation Application - Amendment to Existing Clinical Indication
- Fast Track form
- Horizon Scanning Notification
The approach to annual updating the Test Directory is effective from December 23, 2020. However, for 2021/22, instead of following the annual timescales, NHS England and NHS Improvement implemented a bespoke application window to update the Test Directory - until January 31, 2021.
Relevant application forms should be submitted via email to ENGLAND.testevaluation@nhs.net.
Stakeholders are encouraged to submit applications as soon as possible in advance of the deadline to support the timely evaluation of applications prior to the 2021/22 publication of the Test Directory in April 2021. From April 2021 onwards, NHS England and NHS Improvement will follow the full approach and annual timescales.
The full details can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.